Pancreatic Cancer Research

ResearcherUniversity of UlsterNo recent work listed

John F. Callan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 9 November 2026

Matched on ORCID iD 0000-0002-0608-8299; OpenAlex author ID A5009957180. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
15
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 3 papers · 2022: none · 2023: 2 papers

Papers 9

  1. Nanotechnology-augmented sonodynamic therapy and associated immune-mediated effects for the treatment of pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00432-022-04418-y↗
  2. Correction to: Nanotechnology-augmented sonodynamic therapy and associated immune-mediated effects for the treatment of pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00432-023-04648-8↗
  3. Sonodynamic therapy complements PD-L1 immune checkpoint inhibition in a murine model of pancreatic cancer. Last author DOI 10.1016/j.canlet.2021.06.003↗
  4. Exploiting a Rose Bengal-bearing, oxygen-producing nanoparticle for SDT and associated immune-mediated therapeutic effects in the treatment of pancreatic cance… Co-author DOI 10.1016/j.ejpb.2021.03.005↗
  5. Combining sonodynamic therapy with chemoradiation for the treatment of pancreatic cancer. Co-author DOI 10.1016/j.jconrel.2021.07.020↗
  6. An ultrasound responsive microbubble-liposome conjugate for targeted irinotecan-oxaliplatin treatment of pancreatic cancer. Last author DOI 10.1016/j.ejpb.2020.10.012↗
  7. Gemcitabine loaded microbubbles for targeted chemo-sonodynamic therapy of pancreatic cancer. Last author DOI 10.1016/j.jconrel.2018.04.018↗
  8. Magnetically responsive microbubbles as delivery vehicles for targeted sonodynamic and antimetabolite therapy of pancreatic cancer. Last author DOI 10.1016/j.jconrel.2017.07.040↗
  9. Combined sonodynamic and antimetabolite therapy for the improved treatment of pancreatic cancer using oxygen loaded microbubbles as a delivery vehicle. Last author DOI 10.1016/j.biomaterials.2015.11.033↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. A. P. McHale · 9 shared papers, 2016–2023 · strength 0.94
  2. Heather Nesbitt · 8 shared papers, 2016–2023 · strength 0.83
  3. Nikolitsa Nomikou · 5 shared papers, 2016–2023 · strength 0.53
  4. Keiran A. Logan · 5 shared papers, 2018–2021 · strength 0.52
  5. Mark Taylor · 6 shared papers, 2016–2021 · strength 0.51
  6. Marym Mohammad-Hadi · 2 shared papers, 2023 · strength 0.31
  7. Brian Ritchie Davidson · 2 shared papers, 2023 · strength 0.31
  8. Paul J Kelly · 3 shared papers, 2017–2021 · strength 0.24
  9. Jinhui Gao · 2 shared papers, 2020–2021 · strength 0.23
  10. Yingjie Sheng · 2 shared papers, 2017–2018 · strength 0.13
  11. Dean Nicholas · 1 shared paper, 2021 · strength 0.11
  12. Richard J. Browning · 1 shared paper, 2021 · strength 0.11
  13. Katherine A. Vallis · 1 shared paper, 2021 · strength 0.11
  14. Christiana Kartsonaki · 1 shared paper, 2021 · strength 0.11
  15. Conor McEwan · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.